Reaction
Light Chain Disease reporting signals
As of the last recalculation, Light Chain Disease appears in 145 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is SELINEXOR (PRR 159.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Selinexor | 9 | 159.1 | 159.2 |
| Ixazomib | 26 | 157.8 | 158.0 |
| Carfilzomib | 23 | 138.6 | 138.7 |
| Melphalan | 18 | 129.5 | 129.7 |
| Melphalan Hydrochloride | 19 | 125.0 | 125.1 |
| Daratumumab | 28 | 124.4 | 124.5 |
| Bortezomib | 34 | 71.0 | 71.0 |
| Pomalidomide | 23 | 38.0 | 38.0 |